Pressure BioSciences, Inc. Reports Third Quarter 2019 Financial Results and Provides Business Update
19 déc. 2019 10h03 HE
|
Pressure BioSciences, Inc.
Significant Revenue Growth Reported in Consumable Products (158%) and Scientific Services (87%);Company Continues to Gain Momentum in Its PCT, BaroFold, and UST Technology Platforms Investor...
Pressure BioSciences, Inc. to Discuss Third Quarter 2019 Financial Results and Provide Business Update
18 déc. 2019 08h00 HE
|
Pressure BioSciences, Inc.
SOUTH EASTON, Mass., Dec. 18, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE – Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” and the “Company”) today announced that the Company will host a...
Zacks Small Cap Research Initiates Coverage on Pressure BioSciences, Inc.
04 oct. 2019 08h04 HE
|
Pressure BioSciences, Inc.
SOUTH EASTON, Mass., Oct. 04, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE – Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” or the “Company”), a leader in the development and sale of broadly enabling,...
Pressure BioSciences’ Proprietary PCT Platform Fills Pivotal Role for Tumor Analyses in Novel Workflow Presented at Leading Global Gynecologic Cancer Meeting
01 oct. 2019 07h30 HE
|
Pressure BioSciences, Inc.
SOUTH EASTON, Mass., Oct. 01, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE – Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” or the “Company”), a leader in the development and sale of broadly enabling,...
Pressure BioSciences’ PCT Platform Featured in Multiple Presentations at Major International Science Conference
26 sept. 2019 09h29 HE
|
Pressure BioSciences, Inc.
Ten Presentations by Scientists from Seventeen Research Institutions Worldwide Highlight Novel Applications for PBI’s PCT Platform in Cancer Research and Diagnostics South Easton, MA,...
Pressure BioSciences Prepares for Growth, Adding Daniel J. Shea as Chief Financial Officer
17 sept. 2019 10h33 HE
|
Pressure BioSciences, Inc.
Shea’s 30-Year Diverse Experience in Acquisitions, Capital Markets, SEC Reporting, and Leading Financial Organizations Bolsters PBI’s Strong Senior Management Team South Easton, MA, Sept. 17,...
Pressure BioSciences’ PCT Platform Identified as Pivotal for Cancer Biomarker Discovery and for Potential Clinical Diagnostics
10 sept. 2019 09h33 HE
|
Pressure BioSciences, Inc.
Two Prestigious Research Centers Report PBI’s PCT Platform Delivers Superior Results for Protein Biomarker Discovery Studies from Preserved Cancer Biopsy Tissue Samples SOUTH EASTON, MA,...
Pressure BioSciences Announces Two More Purchase Orders for its Revolutionary BaroShear K45 Processing System for Manufacturing Water-Soluble CBD
22 août 2019 09h08 HE
|
Pressure BioSciences, Inc.
Company Forecasts All 12 Systems in Current Build Cycle Will Be Sold by September 30, 2019 and Reiterates Previous Guidance for More Than Doubling of Annual Revenue in 2020 SOUTH EASTON, MA,...
Uptick Newswire Hosts Pressure BioSciences, Inc. on the Stock Day Podcast to Discuss Their (1) Just Announced Collaboration With NutraFuels, Inc., (2) the Commercial Launch of Their BioPharmaceuticals Contract Services Business, and (3) the Publication of More Than Twenty Scientific Papers on the Company’s Unique Pressure-Based Products During 2018
04 févr. 2019 08h13 HE
|
Pressure BioSciences, Inc.
PHOENIX, Feb. 04, 2019 (GLOBE NEWSWIRE) -- Uptick Newswire Stock Day Podcast welcomed Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the "Company"), a leader in the development and sale of...
Pressure BioSciences Inc. Discusses New Instrument Release, Entry into the Worldwide Food Science Area, and their Innovative Ultra Shear Technology Platform on Uptick Newswire’s Stock Day Podcast
01 oct. 2018 08h30 HE
|
Pressure BioSciences, Inc.
PHOENIX, Oct. 01, 2018 (GLOBE NEWSWIRE) -- Pressure BioSciences Inc. (OTCQB: PBIO) (the “Company”) is a leader in the development and sale of broadly enabling, pressure-based instruments,...